JC BITSOMANG EYE CLINIC announced on September 21 that its Founder and Medical Director,

Dr. Gyung Bai Choi, received a certification plaque from Alcon, a global leader in ophthalmic technology,

in recognition of achieving 1,000 vitrectomy procedures using the Constellation Vision System.

Vitrectomy is a highly specialized surgical procedure performed to treat complex retinal conditions,

including retinal detachment, diabetic retinopathy, macular holes, and vitreous hemorrhage.

The procedure involves the precise removal of the transparent vitreous gel inside the eye to treat and stabilize the retina.

Because even minor damage to the retina can significantly affect vision,

retinal surgery requires meticulous disease assessment and advanced surgical expertise.

While conventional cataract surgery is an anterior segment procedure that involves removing the clouded natural lens and replacing it with an artificial intraocular lens (IOL), vitrectomy is a posterior segment procedure that directly addresses the vitreous and retina deep inside the eye.

Therefore, retinal surgery requires a specialized surgical system capable of precisely cutting and removing the vitreous while carefully regulating intraocular pressure (IOP) and fluid dynamics.

The Constellation Vision System by Alcon, which served as the foundation for this milestone,

is an advanced surgical platform designed for vitreoretinal and cataract procedures.

Equipped with high-speed cutting technology and an automated intraocular pressure control system,

it helps maintain stable IOP throughout surgery, enabling precise vitreous removal and supporting a controlled surgical environment.

Drawing on his extensive clinical experience and advanced surgical expertise,

Dr. Gyung Bai Choi has successfully performed 1,000 retinal surgeries using the Constellation Vision System,

further demonstrating his expertise in ophthalmic surgery.

Dr. Gyung Bai Choi, Founder and Medical Director of JC BITSOMANG EYE CLINIC, stated:

“Early diagnosis and precise surgical intervention play a crucial role in determining visual outcomes for patients with retinal diseases. We will continue to dedicate ourselves to providing safer, more advanced, and differentiated ophthalmic care through state-of-the-art medical technology and ongoing research.”

September 24, 2026 | 9:00 AM

Reporter: Kim Eun-ji Email: admin@medisobizanews.com

Source: Medisobiza News (JC빛소망안과 최경배 대표원장, 알콘 ‘컨스탈레이션 유리체 절제술 1000례’ 인증패 수상 < 기타 < 뉴스 < 기사본문 - 메디소비자뉴스)